Thursday, February 25, 2021

TMH Jamshedpur research study now a part of WHO COVID-19 literature

Jamshedpur, Jan 23: Leading health hub, Tata Main Hospital (TMH) has added another feather in its cap. Research publication titled ‘A Prospective Study on Rapidly Declining SARS-CoV-2 IgG Antibodies within One to Three Months of Testing IgG Positive: Can It Lead to Potential Reinfections?”  from Tata Main Hospital has been published in peer-reviewed indexed international journal.

The research work is indexed in PubMed, the database for the United States National Library of Medicine (NLM) at the National Institute of Health. It has now been included in the World Health Organization COVID-19 Global literature on coronavirus disease (WHO COVID ID: covidwho-962473).

TMH has played a key role in fighting coronavirus.  Tata Steel alone has spent Rs 100 crore in fighting the virus. Tata Main Hospital (TMH), was the first private laboratory in Jharkhand to receive the approval for conducting COVID-19 testing, and it has also achieved the milestone of conducting 1 lakh Covid-19 tests. The tests that were started in May completed 1 lakh mark recently.

The prime health hub of Jamshedpur city has managed a total of 1027 beds for COVID-19 management. TMH is equipped with 83 ventilators for the critical patients. TMH has a team of over 350 doctors and over 2000 paramedical staff.

Officials of the company said that the vision of TMH is to provide state of the art healthcare services to the employees of Tata Steel, their dependants and the community in a fiscally responsible manner. It has been providing medical services to not only people of Jamshedpur but also the communities in which it operates.

It may be mentioned that established in 1907 as a dispensary to provide healthcare facilities to the workers of Tata Steel Works, it has today grown into a hospital providing superior medical assistance to everyone.

Leave a Reply

Stay Connected

- Advertisement -

Latest Articles